Moreover, the ratio of CD8+ T cells over MM cells dictated Cd137 monoclonal antibody efficacy in the transplantable Vk*MYC model of MM, which could be enhanced by depleting Treg cells44. This evidence concerns the gene CD8A and Miyoshi myopathy.